All classes of acid suppression meds raise migraine risk: study
Data on nearly 12,000 people reveals prescription reflux drugs are linked with migraines or severe headaches.
Patients on acid suppression therapy have a higher chance of migraines and other types of severe headaches than those not taking the medications, a US study warns.
All classes — proton-pump inhibitors (PPIs), H2 receptor antagonists (H2RAs) and even generic antacids — appear to promote an increased risk of migraine and headache, results show.
